A pharmacy benefit manager stopped covering a GLP-1 for obesity. Now there’s a lawsuit
Share this
Recent posts
-
Mortality risk may differ across antipsychotics used in Alzheimer’s disease
-
Measles outbreaks linked to increases in immunity testing among adults over 50
-
Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents
-
Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar
-
Understanding real-world patterns of increasing oral semaglutide dose for obesity
Follow Truveta
Stay up-to-date